Assignee
EAGLE PHARMACEUTICALS INC
US·31 granted patents·46 pending applications·318 citations·filing 2007–2025
Top patents by PatentIndex Score
77 records- 0198US12138248B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2024·Granted Nov 12, 2024·3 cites·22 claims
- 0298US11872214B2Formulations of BendamustineEAGLE PHARMACEUTICALS INC·Filed 2022·Granted Jan 16, 2024·3 cites·9 claims
- 0398US11844783B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2022·Granted Dec 19, 2023·5 cites·14 claims
- 0498US11103483B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2019·Granted Aug 31, 2021·9 cites·16 claims
- 0598US9144568B1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2015·Granted Sep 29, 2015·28 cites·23 claims
- 0697US9597399B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2016·Granted Mar 21, 2017·20 cites·17 claims
- 0797US9597397B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2015·Granted Mar 21, 2017·17 cites·7 claims
- 0897US9597398B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2016·Granted Mar 21, 2017·19 cites·10 claims
- 0997US9572887B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2016·Granted Feb 21, 2017·20 cites·29 claims
- 1097US9034908B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2013·Granted May 19, 2015·32 cites·24 claims
- 1196US10052385B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2017·Granted Aug 21, 2018·13 cites·9 claims
- 1296US10010533B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2017·Granted Jul 3, 2018·14 cites·26 claims
- 1396US9572796B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2016·Granted Feb 21, 2017·16 cites·26 claims
- 1496US9572797B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2016·Granted Feb 21, 2017·16 cites·27 claims
- 1596US9572888B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2016·Granted Feb 21, 2017·12 cites·28 claims
- 1696US9265831B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2013·Granted Feb 23, 2016·23 cites·6 claims
- 1794US2026000767A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1893US9000021B2Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administrationEAGLE PHARMACEUTICALS INC·Filed 2013·Granted Apr 7, 2015·30 cites·30 claims
- 1993US2025177356A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2092US12343333B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2024·Granted Jul 1, 2025·0 cites·14 claims
- 2192US9579384B2Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administrationEAGLE PHARMACEUTICALS INC·Filed 2015·Granted Feb 28, 2017·20 cites·23 claims
- 2290US2024075013A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2389US12115164B2Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2023·Granted Oct 15, 2024·0 cites·15 claims
- 2488US2023285563A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2588US2023414623A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2688US2024082264A1Fulvestrant formulationsEAGLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2788US2025295637A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2888US2023390295A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2987US7589106B2Alcohol free formulation of argatrobanEAGLE PHARMACEUTICALS INC·Filed 2007·Granted Sep 15, 2009·4 cites·23 claims
- 3085US2022265829A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3184US11793813B2Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2022·Granted Oct 24, 2023·0 cites·9 claims
- 3284US2023000874A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3384US2022409623A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3484US2022409624A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3584US2022323584A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3683US2020368355A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3783US2022387446A1Fulvestrant formulationsEAGLE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3882US12350257B2Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2025·Granted Jul 8, 2025·0 cites·23 claims
- 3982US2020282057A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4081US11590077B2Fulvestrant formulations and methods of their useEAGLE PHARMACEUTICALS INC·Filed 2018·Granted Feb 28, 2023·2 cites·56 claims
- 4181US2021393594A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4277US2020188411A1Fulvestrant formulationsEAGLE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4376US2019201405A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4475US2021106686A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4574US2019192659A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4674US2025302966A1Fulvestrant formulationsEAGLE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4774US2021260076A1Fulvestrant formulationsEAGLE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4873US2018369383A1Formulations of bendamustineEAGLE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4972US12350339B2Fulvestrant formulationsEAGLE PHARMACEUTICALS INC·Filed 2021·Granted Jul 8, 2025·0 cites·20 claims
- 5072US2018289710A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →